European Union - English - EMA (European Medicines Agency)

akcea therapeutics ireland limited - volanesorsen sodium - hyperlipoproteinemia type i - other lipid modifying agents - waylivra is indicated as an adjunct to diet in adult patients with genetically confirmed familial chylomicronemia syndrome (fcs) and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate.,

United States - English - NLM (National Library of Medicine)

akcea therapeutics, inc. - volanesorsen sodium (unii: 6jon30sldt) (volanesorsen - unii:2o4be0k238) -

Canada - English - Health Canada

teva canada limited - topiramate - tablet - 25mg - topiramate 25mg - miscellaneous anticonvulsants

Canada - English - Health Canada

teva canada limited - topiramate - tablet - 100mg - topiramate 100mg - miscellaneous anticonvulsants

Canada - English - Health Canada

teva canada limited - topiramate - tablet - 200mg - topiramate 200mg - miscellaneous anticonvulsants

Canada - English - Health Canada

nu-pharm inc - topiramate - tablet - 25mg - topiramate 25mg - miscellaneous anticonvulsants

Canada - English - Health Canada

nu-pharm inc - topiramate - tablet - 50mg - topiramate 50mg - miscellaneous anticonvulsants

Canada - English - Health Canada

nu-pharm inc - topiramate - tablet - 100mg - topiramate 100mg - miscellaneous anticonvulsants

Canada - English - Health Canada

nu-pharm inc - topiramate - tablet - 200mg - topiramate 200mg - miscellaneous anticonvulsants

Canada - English - Health Canada

avanstra inc - topiramate - tablet - 25mg - topiramate 25mg - miscellaneous anticonvulsants